Fertile grounds in Asia for private equity investments in healthcare

Spread the love

THERE has never been a better time to raise money for Asian companies in the life sciences sector as the Covid-19 pandemic exposes cracks in the healthcare systems and distribution channels, forcing many in healthcare and insurance to seek innovative solutions.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *